ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 329277 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 329277; 2) Community: the network communities that were significantly associated with the response to NSC 329277; 3) Molecule: the relationships between components within communities and NSC 329277; 4) MDR: the compounds that were significantly associated with the NSC 329277.

NSC Compound Enrichment Correlation
NSC 735037 Camptothecin Derivative 0.0130238833303634 0.23224977
NSC 736609 Null 0.0130238833303634 0.01602724
NSC 740520 6-(3-Bromopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0130238833303634 0.22402669
NSC 748541 1-Methylene-2-(4-methoxybenzyl)-3-(3-chlorophenyl)-1,2-dihydropyrazino[1,2-a]-benzimidazole 0.0130238833303634 0.25486765
NSC 759630 LANATOSIDE C 0.0130238833303634 0.096427415
NSC 98572 .beta.-Resorcylaldehyde, 2-pyridylhydrazone 0.0130238833303634 0.33734814
NSC 668334 Null 0.0135714101922724 0.18799768
NSC 676536 2,5-bis(3-Amino-2,4,6-trinitrophenyl)-1,3,4-thiadiazole 0.0135714101922724 0.22724822
NSC 685833 7H-Purine, 2,6-dichloro- 7-[2-deoxy-3,5-O-bis(4-methylphenyl)- .beta.-D-ribofuranosyl]- 0.0135714101922724 0.20926716
NSC 686505 Null 0.0135714101922724 0.19979207
Total:76  Current:27    [First] [Prev] [Next] [Last]